Trademark: 88788969
Word
ALKERMES
Status
Pending
Status Code
630
Status Date
Tuesday, February 11, 2020
Serial Number
88788969
Mark Type
4000
Filing Date
Friday, February 7, 2020

Trademark Owner History

Classifications
5 Pharmaceutical preparations and compounds for use in treating addiction, substance abuse and dependence, diseases and disorders of the central nervous system, cancer, reward disorders, psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, and bipolar disorder; pharmaceutical preparations for use in treating cardiovascular diseases and metabolic diseases; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidaemia; pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; pharmaceutical preparations and compounds, namely, small molecules and chemical compounds for use in opioid modulation
35 Administration and management of an annual competitive award program in the nature of research grants for scientific research; Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms; appointment reminder services being support services for patients and for health care providers on behalf of their patients
36 Providing grants to organizations dedicated to patient focused medical research; funding service awards to patient advocacy groups and institutions for the treatment and management of diseases including, but not limited to, addiction and central nervous system disorders; Providing information about pharmacies, namely, providing a database featuring information about insurance coverage for pharmaceuticals in the nature of pharmacy selection based on patient health plan coverage requirements; providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs
44 Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about product, namely, pharmaceutical products
45 Support services for health care providers and their patients in the nature of providing patient advocate and case management services, namely, coordinating the procurement of medication in the nature of coordinating with pharmacies to facilitate prescription fulfillment; providing patient advocate and case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement and administration of medication in the nature of locating health care providers that can prescribe and/or administer prescribed medication

Trademark Events
Feb 11, 2020
New Application Office Supplied Data Entered In Tram
Feb 11, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2020-02-14